| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |